Alere Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
September 2018
38
About the Report
About the Report
Summary
Alere Inc (Alere), a subsidiary of Abbott Laboratories, is one of the leading providers of point-of-care diagnostics solutions and services with focus on cardiology, women's health, infectious diseases, diabetes, oncology, and toxicology. It offers testing and monitoring products including point-of-care and laboratory tests within the infectious disease, cardiometabolic disease, toxicology and patient self-testing domains. It also offers diabetic testing supplies, including blood glucose monitors, test strips, lancets, lancing devices, and control solutions, and other related medical supplies in the US. Alere offers its products and services to hospitals, reference laboratories, point-of-care settings, self-insured employees, wholesale and retail drug stores, and mass merchandisers. The company operates through subsidiaries and a network of distributors in the Americas, Europe, the Middle East, Asia-Pacific and Africa. Alere is headquartered in Waltham, Massachusetts, the US.
Alere Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Alere Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Alere Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alere Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alere Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alere Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alere Inc, Medical Devices Deals, 2012 to YTD 2018 9
Alere Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Alere Inc, Pharmaceuticals & Healthcare, Deal Details 11
Debt Offering 11
Alere Completes Private Placement Of Notes Due 2020 For USD 425 Million 11
Alere Completes Private Placement Of Notes Due 2018 For USD 450 Million 13
Acquisition 14
Abbott Labs Acquires Alere 14
Optum Acquires Alere Health for USD600 Million 17
Persivia Acquires Alere Analytics 19
Arriva Medical Acquires Simplex Healthcare 20
Alere Inc-Key Competitors 21
Alere Inc-Key Employees 22
Alere Inc-Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 29
Financial Announcements 29
Aug 03, 2017: Alere Reports Second Quarter 2017 Financial Results 29
Jun 14, 2017: Alere Reports First Quarter 2017 Financial Results 30
Jun 05, 2017: Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2016 Financial Results 31
May 22, 2017: Alere Provides Preliminary Unaudited Financial Results 32
Legal and Regulatory 33
Sep 29, 2017: Alere Announces the U.S. Department of Justice Closes Investigation 33
Sep 28, 2017: Alere Announces Settlement with SEC 34
Mar 09, 2017: Alere Provides Update on Arriva Medical 35
Jan 04, 2017: Alere Laboratory Receives ABFT Accreditation 36
Jan 04, 2017: Alere Provides Update on Arriva Medical 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38
List of Figure
List of Figures
Alere Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Alere Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Alere Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Alere Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alere Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Alere Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alere Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alere Inc, Medical Devices Deals, 2012 to YTD 2018 9
List of Table
List of Tables
Alere Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Alere Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alere Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alere Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alere Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Alere Inc, Medical Devices Deals, 2012 to YTD 2018 9
Alere Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Alere Completes Private Placement Of Notes Due 2020 For USD 425 Million 11
Alere Completes Private Placement Of Notes Due 2018 For USD 450 Million 13
Abbott Labs Acquires Alere 14
Optum Acquires Alere Health for USD600 Million 17
Persivia Acquires Alere Analytics 19
Arriva Medical Acquires Simplex Healthcare 20
Alere Inc, Key Competitors 21
Alere Inc, Key Employees 22
Alere Inc, Subsidiaries 23
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.